News Center

Home page

Peak Report

News reports

Technological Innovation Brings Enterprises to the International Stage

Release time:

2020-07-31

Editor's Note: As a senior enterprise in the extract industry for 17 years, Tianjin Jianfeng Natural Products Research and Development Company has devoted more time, energy and funds to R & D and innovation while doing a good job in business management. It has always been an important direction for them to achieve self breakthrough by turning waste into treasure and technological innovation. Therefore, it has achieved the improvement of market popularity at home and abroad and the rapid growth of sales volume, and has become a key science and technology enterprise in Tianjin Binhai New Area. 7# June 9 , "Bohai Morning Post" "TEDA Technology Little Giant Tour" column published an exclusive interview, telling the growth experience and a series of achievements of Tianjin Jianfeng Natural Products Company. This article will be reproduced in this newspaper for readers.

"Little Grape Seed" Grows into a Little Giant of Science and Technology Solves the Problem of Pesticide Residues in Plant Extracts

Technological Innovation Brings Enterprises to the International Stage

Based on Independent Innovation and Development, Starting from the Initial Grape Seed Extraction Process, it has gradually grown into China's largest professional fruit extract manufacturer with dozens of plant extract products that meet international stringent standards and an annual productivity of ,000 tons. Tianjin Jianfeng Natural Products Research and Development Co., Ltd. (hereinafter referred to as "Tianjin Jianfeng"), a development zone enterprise, has gone through ten years of rapid development. As a supplier of raw materials in health food, beverages, cosmetics, baked goods and many other fields, the concept of "truth and safety" advocated by Tianjin Jianfeng has run through all aspects of R & D and production. Its products are not only well-known in China, but also exported to Europe and the United States. Become a new business card of TEDA.

Technological innovation and international standards

"In people's lives, the beverages they drink, the health foods they eat, and the cosmetics they use all contain plant extracts. For example, grape seed extract is rich in proanthocyanidins, which are natural antioxidants. Therefore, the development of safe and high-quality extract products while reducing waste is the direction of our Tianjin Peak." Liu Dan, general manager of Tianjin Jianfeng, told reporters that after continuous technological innovation, the company has started from grape seed extraction and developed dozens of plant extract products such as apple polyphenols, ginsenosides, anthocyanins, resveratrol, soybean isoflavones, etc. In 2015 , the "JF-NATURAL " brand pure natural pesticide-free dietary supplement developed by the company was recognized as Tianjin's "killer product".

Why can it take the lead in the competition with domestic similar enterprises? Tianjin Jianfeng relies on continuous technological innovation and integration with international standards. "Our products are first and foremost international-oriented, and to be exported we have to meet international standards, so what is the difference between international standards and domestic standards? Simply put, most of the types of pesticide residues in imported products from Europe and the United States are times more than the national standard, which requires us to keep up with the international pace in terms of production processes and quality control." Liu Dan introduced.

In order to create its own brand internationally, it must also be outstanding. Removal of pesticide residues in extracts has always been a technical problem in the plant extraction industry. After years of efforts, Tianjin Jianfeng has invented a method that can not only remove pesticide residues in plant extracts but also retain their active ingredients, which meets the standards for pesticide residues in Europe and the United States, and has applied for a national invention patent. The technology has been successfully applied to the production of apple extract and ginseng extract, and the products are exported to the United States, Europe, Japan and other countries and regions.

Integrates Upstream and Downstream Industrial Resources

In 2015 , Tianjin Peak realized an output value of over 100 million yuan, double that of 5 years ago. Behind the figures are the changes in the two major international and domestic markets. "5 years ago, the international and domestic sales situation was 64, but now it is 46, indicating that the domestic market still has great potential."

While paying attention to expanding cooperation with dozens of domestic industry leaders, Tianjin Jianfeng integrates upstream and downstream industrial resources based on Binhai New Area and continuously expands the development space of enterprises. "in terms of geographical advantages, Binhai New area is rich in grapes, which is not far from the traditional producing areas such as apples and ginseng. At the same time, many of our customer enterprises are also located in Beijing and Tianjin, and there is Tianjin Port, which is convenient for import and export trade. it greatly facilitates the external relations of enterprises." Liu Dan said that the food processing and biomedical industries in Binhai New area are developing very fast, and the agglomeration effect of large enterprises is very conducive to the market expansion and large-scale operation of Tianjin Peak.

In Tianjin Peak, located in Huanghai 3rd Street, Development Zone, Liu Dan pointed to a large open area and said: "Next year, we will use this 30 mu of land to start the second phase of construction, focusing on the reuse of waste after plant extraction. For example, after the production of extracts in the past, grape seeds, grape skins, grapevines and other raw materials have been discarded, but now after years of technological accumulation, the technological level can fully meet the reuse of these wastes and promote the development of related industries. Not only grape series products, all our products must work hard in the direction of turning waste into treasure, and with the help of Binhai New Area, we can better revitalize the upstream and downstream industrial resources. We are confident that we will use another five years to achieve the goal of doubling the output value."

"real money and silver" helps enterprises to engage in research and development

Since entering the development zone in 2004 , Tianjin Jianfeng has gone through 12 years in TEDA. When it comes to the support of the development zone government to enterprises, Liu Dan summarizes it as "real money and silver"; 2005 5 , tianjin Jianfeng has established the first post-doctoral mobile workstation in the plant extraction industry, which has received strong support from the development zone government. Up to now, it has trained 4 post-doctoral talents. In 2008 , with the support of the development zone's policy to promote the development of high-tech industries, Jianfeng Company established an internal research and development organization and won a reward of 100 yuan from the development zone. 2010 , in cooperation with Tianjin Pharmaceutical Research Institute, Tianjin University of Science and Technology, Nankai University School of Pharmacy and Shenyang Pharmaceutical University, the "Tianjin Plant Waste Reuse Technology Engineering Center" was established. In 2015 , Jianfeng Company passed the accreditation of Tianjin Enterprise Technology Center and won the award of Yuan from the Development Zone. 2016 , tianjin Jianfeng Company was listed in the "Development Zone Science and Technology Innovation 20 Enterprises".

Liu Dan recalled, "Over the years, through policy fulfillment, tax incentives, patent and trademark applications, national and municipal science and technology plan projects, fixed asset upgrades and many other fields, we have received millions of yuan in the development zone. Financial support, which greatly reduces the cost of enterprise process technology research and development. Therefore, in the future, we will be based on TEDA, do a good job in the construction of the second phase of the plant, and contribute to TEDA's economic construction." (Bohai Morning Post reporter Xu Xin)

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页